![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 2, 1128-1136, January 11, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





1
From the
Department of Physiology and Pharmacology and
Department of Neuroscience, University of Toledo, College of Medicine, Toledo, Ohio 43614
It is known that the Na/K-ATPase
1 subunit interacts directly with inositol 1,4,5-triphosphate (IP3) receptors. In this study we tested whether this interaction is required for extracellular stimuli to efficiently regulate endoplasmic reticulum (ER) Ca2+ release. Using cultured pig kidney LLC-PK1 cells as a model, we demonstrated that graded knockdown of the cellular Na/K-ATPase
1 subunit resulted in a parallel attenuation of ATP-induced ER Ca2+ release. When the knockdown cells were rescued by knocking in a rat
1, the expression of rat
1 restored not only the cellular Na/K-ATPase but also ATP-induced ER Ca2+ release. Mechanistically, this defect in ATP-induced ER Ca2+ release was neither due to the changes in the amount or the function of cellular IP3 and P2Y receptors nor the ER Ca2+ content. However, the
1 knockdown did redistribute cellular IP3 receptors. The pool of IP3 receptors that resided close to the plasma membrane was abolished. Because changes in the plasma membrane proximity could reduce the efficiency of signal transmission from P2Y receptors to the ER, we further determined the dose-dependent effects of ATP on protein kinase C
activation and ER Ca2+ release. The data showed that the
1 knockdown de-sensitized the ATP-induced ER Ca2+ release but not PKC
activation. Moreover, expression of the N terminus of Na/K-ATPase
1 subunit not only disrupted the formation of the Na/K-ATPase-IP3 receptor complex but also abolished the ATP-induced Ca2+ release. Finally, we observed that the
1 knockdown was also effective in attenuating ER Ca2+ release provoked by angiotensin II and epidermal growth factor.
Received for publication, September 25, 2007 , and in revised form, November 8, 2007.
* This work was supported by National Institutes of Health Grants HL-36573, HL-67963, and GM-78565 and by American Heart Association Grant 0130231N. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Physiology and Pharmacology, the University of Toledo College of Medicine, 3035 Arlington Ave., Toledo, OH 43614-5804. Tel.: 419-383-4182; Fax: 419-383-2871; E-mail: Zi-Jian.Xie{at}utoledo.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |